Two-year FFS according to treatment group among responding patients who are Bcl-6+ and Bcl-6-
Induction and maintenance therapy . | Bcl-6+ . | . | Bcl-6- . | . | . | ||
|---|---|---|---|---|---|---|---|
| . | No. . | 2-y FFS (95% CI) . | No. . | 2-y FFS (95% CI) . | P . | ||
| R-CHOP + MR | 33 | 82 (67, 96) | 5 | 75 (33, 99) | .62 | ||
| CHOP + MR | 25 | 76 (59, 93) | 9 | 89 (68, 99) | .87 | ||
| R-CHOP + OBS | 27 | 65 (47, 84) | 12 | 82 (58, 99) | .12 | ||
| CHOP + OBS | 22 | 64 (44, 84) | 8 | 13 (1, 35) | < .001 | ||
Induction and maintenance therapy . | Bcl-6+ . | . | Bcl-6- . | . | . | ||
|---|---|---|---|---|---|---|---|
| . | No. . | 2-y FFS (95% CI) . | No. . | 2-y FFS (95% CI) . | P . | ||
| R-CHOP + MR | 33 | 82 (67, 96) | 5 | 75 (33, 99) | .62 | ||
| CHOP + MR | 25 | 76 (59, 93) | 9 | 89 (68, 99) | .87 | ||
| R-CHOP + OBS | 27 | 65 (47, 84) | 12 | 82 (58, 99) | .12 | ||
| CHOP + OBS | 22 | 64 (44, 84) | 8 | 13 (1, 35) | < .001 | ||